87 research outputs found

    An integrated approach to define new plays in mature oil basins: the example from the Middle Magdalena Valley basin (Colombia)

    Get PDF
    An integrated approach to detect new areas of potential interest associated with stratigraphic traps in mature basins is presented. The study was carried out in the Middle Magdalena Valley basin, Colombia. The workflow integrates outcrop and subsurface interpretationsoffacies,activityoffaults,anddistributionofdepocenters and paleocurrents and makes use of them to construct a threedimensionalexploration-scalegeocellularfaciesmodelofthebasin. The outcrop and well log sedimentological analysis distinguished faciesassociationsofalluvialfan,overbank, floodplain,andchannel fill,thelastoneconstitutingthereservoirrock.Theseismicanalysis showedthattectonicactivitywas coevalwiththedepositionofthe productive units in the basin and that the activity ended earlier (before the middle Miocene) along the western margin than along the eastern margin. Paleogeographic reconstructions depict transverse and longitudinal fluvial systems, alluvial fans adjacent to the activebasinmargins,and floodplainfaciesdominatingthestructural highs and the southwestern depositional limit. These reconstructions provided statistical data (lateral variograms) to construct the model. The exploration-scale facies model depicts the complete structureofthebasininthreedimensionsandthegrossdistribution of the reservoir and seal rocks. The predictive capability of the model was evaluated positively, and the model was employed to detect zones of high channel fill facies probability that form bodies that are isolated or that terminate upward in pinchouts or are truncated bya fault. Our approach canprovehelpfulinimproving general exploration workflows in similar settings

    Design and Tests of 500kW RF Windows for the ITER LHCD System

    Get PDF
    In the frame of a R\&D effort conducted by CEA toward the design and the qualification of a 5 GHz LHCD system for the ITER tokamak, two 5 GHz 500 kW/5 s windows have been designed, manufactured and tested at high power in collaboration with the National Fusion Research Institute (NFRI). The window design rely on a symmetrical pill-box concept with a cylindrical beryllium oxide ceramic brazed on an actively water cooled copper skirt. The ceramic RF properties have been measured on a test sample to get realistic values for guiding the design. Low power measurements of the manufactured windows show return losses below-32 dB and insertion losses between-0.01 dB and-0.05 dB, with an optimum frequency shifted toward lower frequencies. High power tests conducted at NFRI show unexpected total power loss for both windows. The ceramic temperature during RF pulses has been found to reach unexpected high temperature, preventing these windows to be used under CW conditions. A post-mortem RF analysis of samples taken from one window shows that the dielectric properties of the ceramic were not the ones measured on the manufacturer sample, which partly explain the differences with the reference modelling

    Image resampling and discretization effect on the estimate of myocardial radiomic features from T1 and T2 mapping in hypertrophic cardiomyopathy

    Get PDF
    Radiomics is emerging as a promising and useful tool in cardiac magnetic resonance (CMR) imaging applications. Accordingly, the purpose of this study was to investigate, for the first time, the effect of image resampling/discretization and filtering on radiomic features estimation from quantitative CMR T1 and T2 mapping. Specifically, T1 and T2 maps of 26 patients with hypertrophic cardiomyopathy (HCM) were used to estimate 98 radiomic features for 7 different resampling voxel sizes (at fixed bin width), 9 different bin widths (at fixed resampling voxel size), and 7 different spatial filters (at fixed resampling voxel size/bin width). While we found a remarkable dependence of myocardial radiomic features from T1 and T2 mapping on image filters, many radiomic features showed a limited sensitivity to resampling voxel size/bin width, in terms of intraclass correlation coefficient (> 0.75) and coefficient of variation (< 30%). The estimate of most textural radiomic features showed a linear significant (p < 0.05) correlation with resampling voxel size/bin width. Overall, radiomic features from T2 maps have proven to be less sensitive to image preprocessing than those from T1 maps, especially when varying bin width. Our results might corroborate the potential of radiomics from T1/T2 mapping in HCM and hopefully in other myocardial diseases

    Design and RF measurements of a 5 GHz 500 kW window for the ITER LHCD system

    Get PDF
    International audienceCEA/IRFM is conducting R&D efforts in order to validate the critical RF components of the 5 GHz ITER LHCD system, which is expected to transmit 20 MW of RF power to the plasma. Two 5 GHz 500 kW BeO pill-box type window prototypes have been manufactured in 2012 by the PMB Company, in close collaboration with CEA/IRFM. Both windows have been validated at low power, showing good agreement between measured and modeling, with a return loss better than 32 dB and an insertion loss below 0.05 dB. This paper reports on the window RF design and the low power measurements. The high power tests up to 500kW have been carried out in March 2013 in collaboration with NFRI. Results of these tests are also reported. In the current ITER LHCD design, 20 MW Continuous Wave (CW) of Radio-Frequency power at 5 GHz are expected to be generated and transmitted to the plasma. In order to separate the vacuum vessel pressure from the cryostat waveguide pressure, forty eight 5 GHz 500kW CW windows are to be assembled on the waveguides at the equatorial port flange. For nuclear safety reasons, forty eight additional windows could be located in the cryostat section, to separate and monitor the cryostat waveguide pressure from the exterior transmission line pressure. These windows are identified as being one of the main critical components for the ITER LHCD system since first ITER LHCD studies [1] [2] [3] or more recently [4] [5] , and clearly require an important R&D effort. In this context and even if the LHCD system is not part of the construction baseline, the CEA/IRFM is conducting a R&D effort in order to validate a design and the performances of these RF windows. In order to begin the assessment of this need, two 5 GHz 500 kW/5 s pill-box type windows prototypes have been manufactured in 2012 by the PMB Company in close collaboration with the CEA/IRFM [6]. The section 2 of this paper reports the RF and mechanical design of a 5 GHz window. Some features of the mechanical design and the experimental RF measurements at low power are reported in section 3. High power results, made in collaboration with NFRI, are detailed in section 4. The development of CW windows is discussed in the conclusion. 2-RF AND MECHANICAL DESIGN The proposed 5 GHz RF window is based on a pill-box design [2] , i.e. a ceramic brazed in portion of a circular waveguide, connected on either side to a rectangular waveguide section. Typical design rules of thumb of such device are circular section diameter about the same size of the diagonal of the rectangular waveguide (cf. FIGURE 1). Without taking into account the ceramic, the circular section length is approximately half a guided wavelength of the circular TE 11 mode, in order for the device to act as a half-wave transformer. Once optimized, taking into account the ceramic, matching is correct only for a narrow band of frequency and is very sensitive to the device dimensions and the ceramic relative permittivity. The heat losses in the ceramic, which have to be extracted by an active water cooling, depends on the inside electric field topology and of ceramic dielectric loss (loss tangent). Undesirable modes due to parasitic resonances can be excited in the ceramic volume, raising the electric field an

    Corrigendum: FLASH Radiotherapy With Electrons: Issues Related to the Production, Monitoring, and Dosimetric Characterization of the Beam

    Get PDF
    In the original article, the following authors were missing: Luigi Faillace, Lucia Giuliano, Mauro Migliorati, Luigi Palumbo. The corrected Author Contributions statement appears below. Affiliation 3, ‘Sapienza University of Rome, Rome, Italy’, is also added for authors LF, LG, MM, and LP. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated

    The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

    Get PDF
    The effect of statins on risk of heart failure (HF) hospitalization and HF death remains uncertain. We aimed to establish whether statins reduce major HF events.We searched Medline, EMBASE, and the Cochrane Central Register of Controlled Trials for randomized controlled endpoint statin trials from 1994 to 2014. Collaborating trialists provided unpublished data from adverse event reports. We included primary- and secondary-prevention statin trials with >1000 participants followed for >1 year. Outcomes consisted of first non-fatal HF hospitalization, HF death and a composite of first non-fatal HF hospitalization or HF death. HF events occurring <30 days after within-trial myocardial infarction (MI) were excluded. We calculated risk ratios (RR) with fixed-effects meta-analyses. In up to 17 trials with 132 538 participants conducted over 4.3 [weighted standard deviation (SD) 1.4] years, statin therapy reduced LDL-cholesterol by 0.97 mmol/L (weighted SD 0.38 mmol/L). Statins reduced the numbers of patients experiencing non-fatal HF hospitalization (1344/66 238 vs. 1498/66 330; RR 0.90, 95% confidence interval, CI 0.84-0.97) and the composite HF outcome (1234/57 734 vs. 1344/57 836; RR 0.92, 95% CI 0.85-0.99) but not HF death (213/57 734 vs. 220/57 836; RR 0.97, 95% CI 0.80-1.17). The effect of statins on first non-fatal HF hospitalization was similar whether this was preceded by MI (RR 0.87, 95% CI 0.68-1.11) or not (RR 0.91, 95% CI 0.84-0.98).In primary- and secondary-prevention trials, statins modestly reduced the risks of non-fatal HF hospitalization and a composite of non-fatal HF hospitalization and HF death with no demonstrable difference in risk reduction between those who suffered an MI or not
    corecore